Tianjin First Central Hospital
40
4
4
10
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
2.5%
1 terminated/withdrawn out of 40 trials
90.9%
+4.4% vs industry average
15%
6 trials in Phase 3/4
10%
1 of 10 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (40)
Impact of an Artificial Intelligence-Based Management Model on Psychological and Behavioral Outcomes in Breast Cancer Patients Undergoing Home CDK4/6 Inhibitor Therapy
Role: collaborator
Trial of Acquired Haemophilia With Steroid Combined With Cyclophosphamide Versus Steroid Combined With Rituximab
Role: collaborator
to Evaluate the Efficacy and Safety of Eltrombopag for Immune Thrombocytopenia With Chronic HBV Infection
Role: collaborator
Efficacy and Safety of Tranexamic Acid in Adult Liver Transplantation---ESTA Trial
Role: collaborator
JAK1 Inhibitor Golidocitnib for the Treatment of Relapsed/Refractory Indolent T/NK-cell Lymphomas
Role: collaborator
A Real-world Study of Adebrelimab-based Combination Regimens in the Treatment of Advanced Solid Tumors
Role: lead
Telitacicept for the Treatment of Connective Tissue Disease-associated Thrombocytopenia
Role: collaborator
Chinese Osteoporotic Fracture Registration Network Platform
Role: collaborator
Acute Kidney Injury and Recovery Mode in Pediatric Liver Transplantation
Role: lead
Greater China Metabolic and Bariatric Surgery Database
Role: collaborator
Efficacy of Short Time Intervals in Split-Dose Bowel Preparation of Oral Sulfate Solution for Colonoscopy
Role: collaborator
Coronary Crossing System in Patients With Coronary Chronic Total Occlusions
Role: collaborator
Duloxetine for PHN
Role: collaborator
Systemic Management in Extremely Preterm and Extremely Low Birth Weight Infants
Role: collaborator
Results of Endovascular Treatment for Infrapopliteal Arterial Occlusive Disease.
Role: collaborator
COVID-19 Infection
Role: lead
Risk Factors for Early Acute Lung Injury After Liver Transplantation in Children
Role: lead
FSTL1 and PPCs on Pediatric Within LDLT:a Prospective Cohort Analysis
Role: lead
Effect of Desflurane on Pediatric Acute Respiratory Distress Syndrome After Living Donor Liver Transplant Recipients
Role: lead
A Multicenter Study of Anlotinib in Hepatocellular Carcinoma (HCC) Patients at High Risk of Post Surgery Recurrence
Role: collaborator